News | July 13, 2022
Piramal Pharma Solutions holds opening ceremony for new API Plant at Aurora, Canada
Plant is part of the company's CAD $30 million capital investment in the site
Plant is part of the company's CAD $30 million capital investment in the site
The new facility will be delivered through an investment of approximately CHF 500 million and is expected to be completed in 2026
_256_384.jpg){kind=logo}
Meets the growing need for US-based API solubility and bioavailability enhancement services
The investment will enable the company to provide customers with a complete and integrated end-to-end solution
The Congress was held on June, 20-21, 2022 in Berlin, Germany
This new €59 million, 70,000 square foot facility, officially opened today, brings 50 new jobs to the area
Brings 25 years of global operations and supply chain experience to Piramal
Both manufacturing facilities are based out of Benguluru, India
Stelis's small-scale cGMP manufacturing facility is designed to support smallscale commercial and cGMP clinical trial material generation
Site has a capital investment program of ~$30 million spent or committed over the last three years to expand capabilities and improve operational efficiencies
Subscribe To Our Newsletter & Stay Updated
